1. Nouvel M, Lepape A (2015) Administration des médicaments par voie parentérale : incompatibilités médicamenteuses physicochimiques. Le Congrès Infirmiers Infirmier(e)s de Réanimation 2015
2. Langille SE (2013) Particulate matter in injectable drug products. PDA J Pharm Sci Technol 67:186–200. https://doi.org/10.5731/pdajpst.2013.00922
3. European Pharmacopeia Commission (2020) 2.9.19 Particulate contamination: sub-visible particles. In: Pharmacopoeia, 10th ed. https://www.edqm.eu. Accessed 24 August 2020
4. The United States Pharmacopeia - National Formulary (2012) 788: particulate matters in injections. In: The United States Pharmacopoeia - USP 35-NF 30. https://www.uspnf.com/official-text/revision-bulletins/particulate-matter-injections/. Accessed 24 August 2020
5. European Pharmacopeia Commission (2020) 7. Dosage forms: parenteral preparations. In: Pharmacopoeia, 10th ed. https://pheur-edqm-eu.ressources-electroniques.univ-lille.fr/app/10-2/content/10-2/0520E.htm. Accessed 24 August 2020